Clovis Oncology, Inc.

CITADEL ADVISORS LLC

Report date

9/30/2022

Quarter

2022 Q3

Filed

11/14/2022

Shares

129,979

Value ($000)

155

Weight

0.0%

2013 Q4 - 2022 Q3 (13 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2022 Q3	11/14/2022	155	0.0%	129,979	9/30/2022
2022 Q2	8/15/2022	758	0.0%	421,022	6/30/2022
2022 Q1	5/16/2022	1,094	0.0%	541,514	3/31/2022
2021 Q4	2/14/2022	316	0.0%	116,643	12/31/2021
2021 Q3	11/15/2021	637	0.0%	142,903	9/30/2021
2021 Q2	8/16/2021	733	0.0%	126,330	6/30/2021
2021 Q1	5/21/2021	744	0.0%	105,983	3/31/2021
2020 Q4	2/16/2021	8,917	0.0%	1,857,735	12/31/2020
2020 Q3	11/16/2020	8,888	0.0%	1,524,516	9/30/2020
2020 Q2	8/14/2020	10,748	0.0%	1,592,319	6/30/2020
2019 Q4	2/14/2020	2,014	0.0%	193,154	12/31/2019
2014 Q1	5/15/2014	1,141	0.0%	16,481	3/31/2014
2013 Q4	2/14/2014	261	0.0%	4,332	12/31/2013